Severe Prolonged SGLT2i-induced Euglycemic Diabetic Ketoacidosis Refractory to Standard Therapy and Dialysis: Case Report and Literature Review

Severe Prolonged SGLT2i-induced Euglycemic Diabetic Ketoacidosis Refractory to Standard Therapy and Dialysis: Case Report and Literature Review

Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are oral hypoglycemic agents that have insulin-independent glucose-lowering effects mediated by increasing the renal excretion of glucose by inhibiting the SGLT2-mediated renal glucose reabsorption. An increasingly recognized complication induc...

Full description

Bibliographic Details
Main Authors: Raya Almazrouei, Fatima Alkindi, Aisha Alshamsi, Tasnim Dawoud, Ahmad Chaaban, Masood Ur Rahman
Format: Article
Language:English
Published: Oman Medical Specialty Board 2022-05-01
Series:Oman Medical Journal
Subjects:
sodium-glucose transporter 2 inhibitors
canagliflozin
diabetic ketoacidosis
acidosis
renal dialysis
Online Access:https://omjournal.org/articleDetails.aspx?coType=1&aId=3130

Similar Items

Similar Items